Fundação Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro / O gênero Pterodon pertence à família das Papilonaceas e inclui cinco espécies nativas do Brasil: P. pubescens Benth., P. emarginatus Vog., P. apparicioi Pedersoli e P. abruptus Benth., sendo a espécie objeto deste estudo a P. polygalaeflorus Benth.. Seus frutos são livremente comercializados em mercados da flora medicinal e utilizados pela medicina popular devido a propriedades anti-reumática, analgésica, antiinflamatória, dentre outros efeitos associados a esses frutos. O principal uso popular está relacionado ao efeito antiartrítico que parece se encontrar na fração oleosa do fruto. O objetivo deste trabalho foi avaliar o extrato etanólico de Pterodon polygalaeflorus (EEPpg) quanto ao seu potencial antiinflamatório crônico através do modelo de artrite induzida por colágeno (CIA) e seu efeito sobre os linfócitos in vitro, bem como sobre a expansão de células MAC-1+ induzida por adjuvante completo de Freund (AFC). A caracterização química do EEPpg foi realizada por cromatografia em camada delgada (TLC), cromatografia líquida de alta performance (HPLC) e cromatografia gasosa acoplada a espectrômetro de massa (GC-MS), através dos quais uma gama de compostos, incluindo terpenóides de polaridades variadas e flavonóides, foram observados. No modelo de CIA, o EEPpg reduziu significativamente parâmetros associados ao desenvolvimento e progressão da doença e à severidade da doença , inibindo em até 99% o seu desenvolvimento e levando a ausência de sinais clínicos evidentes após tratamento com as menores doses do extrato (0,01 mg/kg e 0,001 mg/kg). O tratamento com EEPpg também reduziu características histopatológicas típicas de articulações de animais com CIA, que também são observadas na artrite reumatóide. O EEPpg reduziu significativamente o peso dos linfonodos dos camundongos, bem como o número absoluto de segmentados, monócitos e linfócitos no sangue. In vitro, O EEPpg mostrou uma atividade anti-proliferativa dos esplenócitos estimulados com concanavalina A (Con A) ou lipopolissacarídeo (LPS) analisada através do ensaio de redução do sal de tetrazólio MTT, corroborada pelo seu efeito sobre o ciclo celular de linfócitos estimulados com Con A, onde o EEPpg nas concentrações de 5, 10 e 20 μg/mL reduziu significativamente, de maneira concentração-dependente, o número de células nas fases S+G2/M e aumentou na fase G0/G1 do ciclo celular. O efeito anti-proliferativo do EEPpg parece também estar associado ao aumento da apoptose dos linfócitos após estimulação com Con A, com aumento estatisticamente significativo no percentual de células mortas por apoptose nas maiores concentrações . O EEPpg inibiu a expansão de células Mac-1+ induzida por AFC no baço, porém não no peritônio. Esse resultado sugere um efeito inibidor do EEPpg sobre a migração celular para as articulações artríticas. Esses resultados contribuem para a validação do uso popular de P. polygalaeflorus contra doenças relacionadas a processos inflamatórios e imunes, sobretudo na artrite reumatóide, antes nunca demonstrado. / The genus Pterodon belongs to the family Papilonaceas and includes five native species of Brazil: P. pubescens Benth., P. emarginatus Vog., P. apparicioi Pedersoli and P. abruptus Benth., being the object of this study the species P. polygalaeflorus Benth . Its fruits are freely traded in markets and medicinal plants used in folk medicine due to anti-rheumatic, analgesic, antiinflammatory, among other effects associated with these fruits. The main use is related to the popular anti-arthritic effect that seems to be found in oily fraction of the fruit. The aim of this study was to evaluate the ethanol extract of Pterodon polygalaeflorus (EEPpg) for their potential anti-inflammatory chronic through the model of collagen-induced arthritis (CIA) and its effect on lymphocytes in vitro, as well as the MAC-cell expansion 1 + induced by Freund's complete adjuvant (CFA). The chemical characterization of EEPpg was performed by thin layer chromatography (TLC), high-performance liquid chromatography (HPLC) and gas chromatography coupled with mass spectrometry (GC-MS), through which a range of compounds, including terpenoids polarity varied and flavonoids, were observed. In model of CIA, EEPpg significantly reduced parameters associated with the development and progression of disease and disease severity, inhibiting up to 99% its development and leading to the absence of obvious clinical signs after treatment with lower doses of the extract (0,01 mg/kg and 0.001 mg/kg). Treatment with EEPpg also reduced histopathological features typical of arthritic joints that are also observed in rheumatoid arthritis. The EEPpg significantly reduced the weight of the lymph nodes of mice as well as the absolute number of segmented, monocytes and lymphocytes in the blood. In vitro, EEPpg showed an anti-proliferative activity of splenocytes stimulated with concanavalin A (Con A) or lipopolysaccharide (LPS) analyzed by testing to reduce the tetrazolium salt MTT, supported by its effect on the cell cycle of lymphocytes stimulated with Con A, where the EEPpg at concentrations of 5, 10 and 20 mg/mL significantly reduced in concentration-dependent manner, the number of cells in phases S + G2 / M and increased G0/G1 phase of cell cycle. The anti-proliferative EEPpg seems also to be associated with increased apoptosis of lymphocytes after stimulation with Con A, with a statistically significant increase in the percentage of dead cells by apoptosis at higher concentrations. The EEPpg inhibited the expansion of Mac-1 + cells induced by AFC in the spleen but not in the peritoneum. This suggests an inhibitory effect on cell migration by EEPpg into arthritic joints. These results help to validate the popular use of P. polygalaeflorus against diseases related to inflammatory and immune disorders, especially rheumatoid arthritis, never shown before.

La LMMC est une pathologie clonale de la cellule souche hématopoïétique dont les caractéristiques la classent parmi les syndromes myélodysplasiques/myéloprolifératifs (SMD/SMP). L’invalidation conditionnelle de Tif1γ au niveau hématopoïétique chez la Souris (Tif1γΔ/Δ) est responsable du développement d’un SMD/SMP mimant la LMMC humaine lorsque la souris atteint l’âge de 6 mois, faisant de Tif1γ un gène suppresseur de tumeur. Par ailleurs, malgré une monocytose, la population macrophagique péritonéale de ces souris est diminuée.Les objectifs de mon travail étaient de caractériser chez les souris malades la population myéloïde et d’étudier la différenciation macrophagique. Nous avons identifié chez les souris homozygotes Tif1γΔ/Δ une population morphologiquement immature, associant des caractéristiques granulocytaires et monocytaires. Les propriétés phénotypiques et moléculaires de cette population évoquent celles des cellules myéloïdes suppressives granulocytaires de type PMN-MDSC, faisant de Tif1γ un régulateur négatif de son développement. En sus, la différenciation in vitro des cellules myéloïdes médullaires en macrophages sous l’effet du CSF-1 est altérée. La baisse d’expression du CSF-1R n’explique pas à elle seule ces altérations puisque celle des cellules dendritiques est également perturbée sans modification de l’expression du GM-CSFR. Nous émettons l’hypothèse que l’augmentation d’expression de S100A8 et S100A9 chez les souris malades induit le développement des progéniteurs myéloïdes en cellules proches des PMN-MDSC au détriment des différenciations dendritique et macrophagique. En conclusion, Tif1γ est un régulateur majeur de la myélopoïèse. / Chronic myelomonocytic leukemia (CMML) is a hematologic stem cell disease whose characteristics correspond to myelodysplastic/myeloproliferative syndroms (MDS/MPS). Hematopoietic conditional deletion of Tif1γ in mice leads to the development of a MDS/MPS, mimiking human CMML, when age is comprised between 6 to 10 months, defining Tif1γ as a tumour suppressor gene. Moreover, peritoneal macrophage population in these mice is decreased despite a monocytosis.The aims of my work were first to characterize in sick mice the myeloid population, and second to study macrophage differentiation. The myeloid population in Tif1γΔ/Δ mice is morphologically immature, with granulocytic and monocytic features. We demonstrated that phenotypic and molecular characteristics of this population are close to those observed in PMN-MDSC (polymorphonuclear myeloid-derived suppressor cells), suggesting that Tif1γ is a negative regulator gene of this myeloid subset. Furthermore, we showed that in vitro macrophage differentiation of myeloid progenitors upon CSF-1 treatment is altered. Decreased expression of CSF1-R (CSF-1 receptor) does not totally explain this alteration since dendritic cell differentiation is also abnormal, without alteration in GM-CSFR expression. Therefore, we hypothesize that S100A8 and S100A9 hyperexpression in Tif1γΔ/Δ mice is able to promote PMN-MDSC-like differentiation at the expense of macrophage and dendritic differentiations. In conclusion, Tif1γ is a major myelopoiesis regulator gene.

Fundação Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro / O gênero Pterodon pertence à família das Papilonaceas e inclui cinco espécies nativas do Brasil: P. pubescens Benth., P. emarginatus Vog., P. apparicioi Pedersoli e P. abruptus Benth., sendo a espécie objeto deste estudo a P. polygalaeflorus Benth.. Seus frutos são livremente comercializados em mercados da flora medicinal e utilizados pela medicina popular devido a propriedades anti-reumática, analgésica, antiinflamatória, dentre outros efeitos associados a esses frutos. O principal uso popular está relacionado ao efeito antiartrítico que parece se encontrar na fração oleosa do fruto. O objetivo deste trabalho foi avaliar o extrato etanólico de Pterodon polygalaeflorus (EEPpg) quanto ao seu potencial antiinflamatório crônico através do modelo de artrite induzida por colágeno (CIA) e seu efeito sobre os linfócitos in vitro, bem como sobre a expansão de células MAC-1+ induzida por adjuvante completo de Freund (AFC). A caracterização química do EEPpg foi realizada por cromatografia em camada delgada (TLC), cromatografia líquida de alta performance (HPLC) e cromatografia gasosa acoplada a espectrômetro de massa (GC-MS), através dos quais uma gama de compostos, incluindo terpenóides de polaridades variadas e flavonóides, foram observados. No modelo de CIA, o EEPpg reduziu significativamente parâmetros associados ao desenvolvimento e progressão da doença e à severidade da doença , inibindo em até 99% o seu desenvolvimento e levando a ausência de sinais clínicos evidentes após tratamento com as menores doses do extrato (0,01 mg/kg e 0,001 mg/kg). O tratamento com EEPpg também reduziu características histopatológicas típicas de articulações de animais com CIA, que também são observadas na artrite reumatóide. O EEPpg reduziu significativamente o peso dos linfonodos dos camundongos, bem como o número absoluto de segmentados, monócitos e linfócitos no sangue. In vitro, O EEPpg mostrou uma atividade anti-proliferativa dos esplenócitos estimulados com concanavalina A (Con A) ou lipopolissacarídeo (LPS) analisada através do ensaio de redução do sal de tetrazólio MTT, corroborada pelo seu efeito sobre o ciclo celular de linfócitos estimulados com Con A, onde o EEPpg nas concentrações de 5, 10 e 20 μg/mL reduziu significativamente, de maneira concentração-dependente, o número de células nas fases S+G2/M e aumentou na fase G0/G1 do ciclo celular. O efeito anti-proliferativo do EEPpg parece também estar associado ao aumento da apoptose dos linfócitos após estimulação com Con A, com aumento estatisticamente significativo no percentual de células mortas por apoptose nas maiores concentrações . O EEPpg inibiu a expansão de células Mac-1+ induzida por AFC no baço, porém não no peritônio. Esse resultado sugere um efeito inibidor do EEPpg sobre a migração celular para as articulações artríticas. Esses resultados contribuem para a validação do uso popular de P. polygalaeflorus contra doenças relacionadas a processos inflamatórios e imunes, sobretudo na artrite reumatóide, antes nunca demonstrado. / The genus Pterodon belongs to the family Papilonaceas and includes five native species of Brazil: P. pubescens Benth., P. emarginatus Vog., P. apparicioi Pedersoli and P. abruptus Benth., being the object of this study the species P. polygalaeflorus Benth . Its fruits are freely traded in markets and medicinal plants used in folk medicine due to anti-rheumatic, analgesic, antiinflammatory, among other effects associated with these fruits. The main use is related to the popular anti-arthritic effect that seems to be found in oily fraction of the fruit. The aim of this study was to evaluate the ethanol extract of Pterodon polygalaeflorus (EEPpg) for their potential anti-inflammatory chronic through the model of collagen-induced arthritis (CIA) and its effect on lymphocytes in vitro, as well as the MAC-cell expansion 1 + induced by Freund's complete adjuvant (CFA). The chemical characterization of EEPpg was performed by thin layer chromatography (TLC), high-performance liquid chromatography (HPLC) and gas chromatography coupled with mass spectrometry (GC-MS), through which a range of compounds, including terpenoids polarity varied and flavonoids, were observed. In model of CIA, EEPpg significantly reduced parameters associated with the development and progression of disease and disease severity, inhibiting up to 99% its development and leading to the absence of obvious clinical signs after treatment with lower doses of the extract (0,01 mg/kg and 0.001 mg/kg). Treatment with EEPpg also reduced histopathological features typical of arthritic joints that are also observed in rheumatoid arthritis. The EEPpg significantly reduced the weight of the lymph nodes of mice as well as the absolute number of segmented, monocytes and lymphocytes in the blood. In vitro, EEPpg showed an anti-proliferative activity of splenocytes stimulated with concanavalin A (Con A) or lipopolysaccharide (LPS) analyzed by testing to reduce the tetrazolium salt MTT, supported by its effect on the cell cycle of lymphocytes stimulated with Con A, where the EEPpg at concentrations of 5, 10 and 20 mg/mL significantly reduced in concentration-dependent manner, the number of cells in phases S + G2 / M and increased G0/G1 phase of cell cycle. The anti-proliferative EEPpg seems also to be associated with increased apoptosis of lymphocytes after stimulation with Con A, with a statistically significant increase in the percentage of dead cells by apoptosis at higher concentrations. The EEPpg inhibited the expansion of Mac-1 + cells induced by AFC in the spleen but not in the peritoneum. This suggests an inhibitory effect on cell migration by EEPpg into arthritic joints. These results help to validate the popular use of P. polygalaeflorus against diseases related to inflammatory and immune disorders, especially rheumatoid arthritis, never shown before.

An intact and fully functional innate immune system is critical in the defense against pathogens. Indeed, during systemic infection, the ability of the organism to cope with the increased demand for phagocytes depends heavily on sufficient replenishment of mature myeloid cells. This process, designated emergency or demand-adapted myelopoiesis, requires the activation of hematopoietic progenitors in the bone marrow (BM), resulting in their proliferation and differentiation toward the myeloid lineage. Failure of BM progenitors to adapt to the enhanced need for mature cells in the periphery can be life-threatening, as indicated by the detrimental effect of chemotherapy-induced myelosuppression on the outcome of systemic infection. Recent advances demonstrate an important role of not only committed myeloid progenitors but also of hematopoietic stem cells (HSCs) in emergency myelopoiesis. In this regard, pathogen-derived products (e.g., Toll-like receptor ligands) activate HSC differentiation towards the myeloid lineage, either directly or indirectly, by inducing the production of inflammatory mediators (e.g., cytokines and growth factors) by hematopoietic and nonhematopoietic cell populations. The inflammatory mediators driving demand-adapted myelopoiesis target not only HSCs but also HSC-supportive cell populations, collectively known as the HSC niche, the microenvironment where HSCs reside. In this review, we discuss recent findings that have further elucidated the mechanisms that drive emergency myelopoiesis, focusing on the interactions of HSCs with their BM microenvironment.

No description available.

Les facteurs régulant l’hématopoïèse en contexte de vieillissement s’avèrent incomplètement compris. Nous avons étudié les déterminants de la variabilité des traits de la formule sanguine complète dans une cohorte de 2996 femmes apparentées et non-apparentées d’ascendance française du Québec âgées de 55 à 101 ans. Les déterminants héréditaires ont été évalués par étude d’association pan-génomique. Des facteurs acquis, incluant comorbidités et hématopoïèse clonale, ont aussi été évalués. Des analyses multivariées ont été réalisées avec des modèles linéaires mixtes généralisés. Nous avons identifié des variants dans la région de GSDMA et PSMD3-CSF3 significativement associés au décompte de neutrophiles et un polymorphisme intronique à ARHGEF3 associé au décompte plaquettaire. L’effet de certains variants diminuait avec l’âge. Avec l’âge, les décomptes de neutrophiles et monocytes augmentaient tandis que le décompte des lymphocytes décroissait. Les valeurs de neutrophiles (4,1x109/L vs 3,83x109/L, valeur-p <0,001), monocytes (0,50x109/L vs 0,45x109/L, valeur-p <0,001) et plaquettes (259x109/L vs 243x109/L, valeur-p <0,001) étaient augmentées lors de comorbidités cardiométaboliques (maladie coronarienne, hypertension, diabète, dyslipidémie). L’hématopoïèse clonale ne modifiait pas les décomptes. En conclusion, nous identifions des déterminants génétiques héréditaires contribuant à la variabilité des décomptes cellulaires sanguins dans une cohorte vieillissante. De plus, le vieillissement est associé à des niveaux accrus de neutrophiles et monocytes et une diminution des lymphocytes indiquant un biais myéloïde, lequel est majoré lors de comorbidités métaboliques. L’hématopoïèse clonale ne contribue pas à ce biais myéloïde. Ces résultats supportent le fait que des facteurs extrinsèques, possiblement via un effet inflammatoire, promeuvent le biais myéloïde relié à l’âge. / Our understanding of the factors regulating peripheral blood cell traits in the setting of aging remains incomplete. We investigated the determinants underlying blood cell trait variability in a cohort of 2996 related and unrelated women of French ancestry from Québec aged 55 to 101 years. We performed a genome-wide association study to assess for genetic variants. We also assessed the impact of acquired factors such as chronic comorbidities and clonal hematopoiesis. Multivariate analyses were subsequently performed using generalized linear mixed models. We identify variants in the region of GSDMA and PSMD3-CSF3 that meet genome-wide requirements for neutrophil counts and a variant intronic to ARHGEF3 for platelet counts. With aging, the effect of certain variants decreased. Aging was associated with increasing neutrophil and monocyte counts and decreasing lymphocyte counts. We also document that individuals with cardiometabolic comorbidities (diabetes, coronary heart disease, hypertension and dyslipidemia) exhibit significantly higher neutrophil (4.1x109/L vs 3.83x109/L, p-value <0.001), monocyte (0.50x109/L vs 0.45x109/L p-value <0.001), and platelet (259x109/L vs 243x109/L, p-value <0.001) counts. Clonal hematopoiesis did not contribute significantly to these traits. In conclusion, germline variants related to GSDMA and PSMD3-CSF3 contribute to neutrophil counts and a SNP intronic to ARHGEF3 contributes to platelet counts. Aging is associated with a myeloid shift with increased levels of neutrophils and monocytes, and reduced lymphocyte counts. This myeloid-biased skewing is further increased with cardiometabolic comorbidities. Clonal hematopoiesis does not contribute to this phenomenon. These findings support that cellextrinsic factors may contribute to the myeloid shift possibly through low-grade inflammation.

The principle of trained immunity represents innate immune memory due to sustained, mainly epigenetic, changes triggered by endogenous or exogenous stimuli in bone marrow (BM) progenitors (central trained immunity) and their innate immune cell progeny, thereby triggering elevated responsiveness against secondary stimuli. BM progenitors can respond to microbial and sterile signals, thereby possibly acquiring trained immunity-mediated long-lasting alterations that may shape the fate and function of their progeny, for example, neutrophils. Neutrophils, the most abundant innate immune cell population, are produced in the BM from committed progenitor cells in a process designated granulopoiesis. Neutrophils are the first responders against infectious or inflammatory challenges and have versatile functions in immunity. Together with other innate immune cells, neutrophils are effectors of peripheral trained immunity. However, given the short lifetime of neutrophils, their ability to acquire immunological memory may lie in the central training of their BM progenitors resulting in generation of reprogrammed, that is, “trained”, neutrophils. Although trained immunity may have beneficial effects in infection or cancer, it may also mediate detrimental outcomes in chronic inflammation. Here, we review the emerging research area of trained immunity with a particular emphasis on the role of neutrophils and granulopoiesis.